Provention Bio

TZIELD

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Provention Bio

Tzield HCPCS:

C9149

HCPCS Code Descriptor:

Injection, teplizumab-mzwv, 5 mcg

Category:

C Code

Tzield NDCs:

No actively aligned NDCs found

Primary Type:

Diabetes

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Tzield CPT Codes:

Potential CPT administration codes for Tzield can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Tzield:

TZIELD is a Diabetes drug manufactured by Provention Bio and administered via the Intravenous route of administration. The C Code: C9149 is aligned to the drug TZIELD.

ACCESS PRICING AND MORE BY REGISTERING

C9149 Added Date:

April 1, 2023

C9149 Effective Date:

July 1, 2023

C9149 Termination Date:

June 30, 2023

We have not yet identified a manufacturer source of Tzield billing and coding information.
Tzield patient assistance information can be found through Provention Bio COMPASS at the URL: https://www.tzieldhcp.com/patient-support
TZIELD prescribing information can be found at the link below:
Information regarding TZIELD’s side effects can be found at MedlinePlus